Who Owns Aetna?

CVS Health publishes an annual ESG report covering Aetna's health equity, access, and social impact activities alongside broader corporate sustainability metrics. Key commitments relevant to Aetna include:

Health Equity: CVS Health has committed to investing $100 million over five years in health equity initiatives, including programs addressing social determinants of health in communities where Aetna members live. Aetna participates in the CMS (Centers for Medicare and Medicaid Services) Health Equity Framework under Medicare Advantage regulations.

Member Access: Aetna's behavioral health network coverage and parity compliance have been areas of regulatory focus. Multiple states have audited insurance companies including Aetna for compliance with the Mental Health Parity and Addiction Equity Act, which requires equivalent coverage for mental health and substance use disorder benefits as for medical/surgical benefits.

Environmental: CVS Health has committed to carbon neutrality for its operations by 2050 and has set interim targets for greenhouse gas emission reduction. Aetna's office operations are included in CVS Health's enterprise environmental targets.

Aetna does not hold independent sustainability certifications beyond its participation in CVS Health's corporate ESG reporting framework.

• J.D. Power: Aetna has ranked among the top commercial health plans in several J.D. Power Member Health Plan Satisfaction Studies for customer service and care management in specific regional markets.
• Fortune 500: CVS Health consistently ranks in the top 10 of the Fortune 500; Aetna's revenues are consolidated within this ranking.
• Human Rights Campaign Corporate Equality Index: Aetna/CVS Health has scored 100 on the HRC Corporate Equality Index for LGBTQ+ workplace inclusion in multiple years.
• NCQA Health Plan Accreditation: Aetna's commercial and Medicare health plans hold National Committee for Quality Assurance (NCQA) accreditation in most of their operating markets, a key quality indicator in managed care.
• URAC Accreditation: Aetna's utilization management and case management programs hold URAC accreditation for health plan quality standards.

HIV Status Disclosure Breach (August 2017): Aetna mailed letters to approximately 12,000 HIV-positive members in window envelopes through which the HIV status references were visible. The incident occurred shortly before the CVS acquisition announcement. Aetna settled a class action lawsuit in 2018 for approximately $17 million. Several state attorneys general also investigated and reached separate settlements totaling approximately $1.15 million. The incident drew significant media attention and criticism from HIV advocacy organizations, who described it as a serious violation of medical privacy.

ACA Exchange Withdrawal and Merger Allegation (2017): A federal judge ruled in January 2017 that Aetna had misled the court during the review of its proposed acquisition of Humana. The judge found that Aetna's withdrawal from ACA exchanges in 11 states in 2016 was partly motivated by its attempt to create leverage in the Humana merger review, rather than being purely a business decision as Aetna had stated publicly. The DOJ blocked the Humana merger in January 2017. Aetna denied the judge's characterization. The episode reinforced scrutiny of large insurer mergers.

Medicare Advantage Overpayment Investigation: Aetna, along with other large Medicare Advantage insurers, has been the subject of federal investigation and litigation over risk adjustment practices. The DOJ has pursued False Claims Act cases against multiple insurers alleging that they submitted inflated risk scores for Medicare Advantage members to collect higher payments from the federal government. Aetna settled a related DOJ investigation in 2021 for approximately $1 million, a relatively small settlement compared to some competitor settlements.

Prior Authorization Denial Rates: Aetna has been named in reporting and congressional testimony regarding high prior authorization denial rates for certain medical procedures and treatments. A 2024 U.S. Senate investigation examined AI-assisted prior authorization denial practices at several major insurers including Aetna. CVS Health responded that its prior authorization processes comply with clinical and regulatory standards. The issue is industry-wide but Aetna's scale makes it a prominent target of advocacy group criticism.

CVS Acquisition Antitrust Concerns: The 2018 CVS-Aetna merger drew objections from consumer advocates, some healthcare economists, and state attorneys general who argued the vertical integration of a major pharmacy chain, pharmacy benefit manager, and health insurer would give CVS Health anticompetitive leverage over healthcare pricing. The DOJ approved the merger subject to the Part D divestiture condition, but critics argued the structural concerns were not adequately addressed. Several state AG offices conducted their own reviews and ultimately did not block the transaction.